Between us, we bring two perspectives to persistent illness: personal experience of long COVID and clinical and research ...

Construction leads filings while post-COVID default trends show no signs of slowing This 35% increase is a clear signal ...

Sepsis is a life-threatening medical emergency that affects millions of people each year. In the U.S., at least 1.7 million adults and more than 18,000 children develop sepsis annually, and many cases ...

Two Alabama cities are now ranked among America’s fastest-growing boomtowns, fueled by job gains, population growth and housing expansion. Here's where.

A study on Covid vaccines that the Centers for Disease Control and Prevention’s acting director blocked from publication came out Tuesday in a different journal. Subscribe to read this story ad-free ...

The coronavirus vaccine reduced the risk of major cardiovascular events linked to covid-19 — strokes, heart attacks, and hospitalization from heart disease — by about 40 percent, according to a new ...

Lauren writes about healthcare AI data interoperability, the science behind public health recommendations, and pharmaceutical advances in the rare disease space. Recent Covid vaccination appears to ...

JACKSONVILLE, Fla. — Stroke remains a leading cause of serious disability and death in the U.S., but recognizing symptoms quickly and seeking immediate medical attention can dramatically improve ...

The Department of War has officially removed 180 faiths from its list of recognized religions, acting on a change previously announced by War Secretary Pete Hegseth. The U.S. Military Chaplain Corps ...

Psychosis and schizophrenia are among the most common mental health concerns. Yet, these terms remain draped in misunderstanding, even among clinicians. As a therapist who has experienced psychosis ...

Spring days have arrived. Leaves are popping out and providing that lovely spring greenery, flowers finally decorate the landscape, and grass cutting season has begun ...

Ensitrelvir, an oral inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3C-like protease, is approved in Japan for the treatment of mild-to-moderate coronavirus disease 2019 ...